Endurance Wealth Management, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History
Endurance Wealth Management, Inc.
- $731 Million
- Q2 2023
A detailed history of Endurance Wealth Management, Inc. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Endurance Wealth Management, Inc. holds 20,000 shares of DNA stock, worth $187,399. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$187,399
Previous $27,000
37.04%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DNA
# of Institutions
40Shares Held
48.1MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY42MShares$394 Million0.0% of portfolio
-
Titleist Asset Management, Ltd. San Antonio, TX2.31MShares$21.6 Million0.92% of portfolio
-
Putnam Investments LLC Boston, MA1.5MShares$14.1 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.15MShares$10.7 Million0.0% of portfolio
-
Benjamin F. Edwards & Company, Inc. St. Louis, MO235KShares$2.2 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $12.1B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...